Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis.

Cai T, Dufour JF, Muellhaupt B, Gerlach T, Heim M, Moradpour D, Cerny A, Malinverni R, Kaddai V, Bochud M, Negro F, Bochud PY.

J Hepatol. 2011 Sep;55(3):529-535. doi: 10.1016/j.jhep.2010.12.020. Epub 2011 Jan 12.

PMID:
21236304
2.

PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C.

Ampuero J, Del Campo JA, Rojas L, García-Lozano JR, Solá R, Andrade R, Pons JA, Navarro JM, Calleja JL, Buti M, González-Escribano MF, Forns X, Diago M, García-Samaniego J, Romero-Gómez M.

Ann Hepatol. 2014 Jul-Aug;13(4):356-63.

3.

The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.

Clark PJ, Thompson AJ, Zhu Q, Vock DM, Zhu M, Patel K, Harrison SA, Naggie S, Ge D, Tillmann HL, Urban TJ, Shianna K, Fellay J, Goodman Z, Noviello S, Pedicone LD, Afdhal N, Sulkowski M, Albrecht JK, Goldstein DB, McHutchison JG, Muir AJ.

Dig Dis Sci. 2012 Aug;57(8):2213-21. doi: 10.1007/s10620-012-2171-y. Epub 2012 Apr 29. Erratum in: Dig Dis Sci. 2012 Sep;57(9):2479.

4.

No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.

Nakamura M, Kanda T, Nakamoto S, Miyamura T, Jiang X, Wu S, Yokosuka O.

PLoS One. 2013 Dec 11;8(12):e81312. doi: 10.1371/journal.pone.0081312. eCollection 2013.

5.

The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.

Manchiero C, Nunes AKDS, Magri MC, Dantas BP, Mazza CC, Barone AA, Tengan FM.

BMC Infect Dis. 2017 Dec 19;17(1):780. doi: 10.1186/s12879-017-2887-6.

6.

Impact of comorbid hepatic steatosis on treatment of chronic hepatitis C in Japanese patients and the relationship with genetic polymorphism of IL28B, PNPLA3 and LDL receptor.

Moritou Y, Ikeda F, Iwasaki Y, Baba N, Takaguchi K, Senoh T, Nagano T, Takeuchi Y, Yasunaka T, Ohnishi H, Miyake Y, Takaki A, Nouso K, Yamamoto K.

Acta Med Okayama. 2014;68(1):17-22.

7.

Genetic variation in the microsomal triglyceride transfer protein (-493G/T) is associated with hepatic steatosis in patients infected with hepatitis C virus.

Magri MC, Prata TV, Manchiero C, Dantas BP, Mazza CC, Tengan FM.

BMC Infect Dis. 2017 Mar 29;17(1):235. doi: 10.1186/s12879-017-2340-x.

8.

Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.

Stättermayer AF, Rutter K, Beinhardt S, Scherzer TM, Stadlmayr A, Hofer H, Wrba F, Steindl-Munda P, Krebs M, Datz C, Trauner M, Ferenci P.

J Hepatol. 2012 Sep;57(3):492-8. doi: 10.1016/j.jhep.2012.04.036. Epub 2012 May 24.

PMID:
22634340
9.

TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.

Petta S, Maida M, Grimaudo S, Pipitone RM, Macaluso FS, Cabibi D, Cammà C, Di Marco V, Sferrazza S, Craxì A.

Liver Int. 2016 Feb;36(2):198-204. doi: 10.1111/liv.12918. Epub 2015 Aug 8.

PMID:
26259026
10.

Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3.

Rembeck K, Alsiö A, Christensen PB, Färkkilä M, Langeland N, Buhl MR, Pedersen C, Mørch K, Westin J, Lindh M, Hellstrand K, Norkrans G, Lagging M.

PLoS One. 2012;7(1):e29370. doi: 10.1371/journal.pone.0029370. Epub 2012 Jan 13.

11.

The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.

Scheiner B, Mandorfer M, Schwabl P, Payer BA, Bucsics T, Bota S, Aichelburg MC, Grabmeier-Pfistershammer K, Stättermayer A, Ferenci P, Trauner M, Peck-Radosavljevic M, Reiberger T.

PLoS One. 2015 Nov 23;10(11):e0143429. doi: 10.1371/journal.pone.0143429. eCollection 2015.

12.

Impact of IL28B and PNPLA3 polymorphisms on treatment outcomes in patients infected with genotype 6 hepatitis C virus.

Wong GL, Chan HL, Tse CH, Chan PO, Cheng JC, Cheng JS, Lau SH, Lee EK, Ma JM, Chan AW, Choi PC, Wong VW.

J Gastroenterol Hepatol. 2015 Jun;30(6):1040-8. doi: 10.1111/jgh.12890.

PMID:
25639146
13.

Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.

Zampino R, Coppola N, Cirillo G, Boemio A, Pisaturo M, Marrone A, Macera M, Sagnelli E, Perrone L, Adinolfi LE, Miraglia del Giudice E.

J Viral Hepat. 2013 Aug;20(8):517-23. doi: 10.1111/jvh.12053. Epub 2013 Jan 7.

PMID:
23808989
14.

Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.

Valenti L, Maggioni P, Piperno A, Rametta R, Pelucchi S, Mariani R, Dongiovanni P, Fracanzani AL, Fargion S.

World J Gastroenterol. 2012 Jun 14;18(22):2813-20. doi: 10.3748/wjg.v18.i22.2813.

15.

PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection.

Rembeck K, Maglio C, Lagging M, Christensen PB, Färkkilä M, Langeland N, Buhl MR, Pedersen C, Mørch K, Norkrans G, Hellstrand K, Lindh M, Pirazzi C, Burza MA, Romeo S, Westin J; NORDynamIC group.

BMC Med Genet. 2012 Sep 14;13:82. doi: 10.1186/1471-2350-13-82.

16.

Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.

Valenti L, Rumi M, Galmozzi E, Aghemo A, Del Menico B, De Nicola S, Dongiovanni P, Maggioni M, Fracanzani AL, Rametta R, Colombo M, Fargion S.

Hepatology. 2011 Mar;53(3):791-9. doi: 10.1002/hep.24123. Epub 2011 Feb 11.

PMID:
21319195
17.

The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent.

D'Ambrosio R, Aghemo A, De Francesco R, Rumi MG, Galmozzi E, De Nicola S, Cheroni C, Clark PJ, Ronchi G, Lampertico P, Colombo M.

Int J Mol Sci. 2014 Apr 25;15(5):7213-24. doi: 10.3390/ijms15057213.

18.

Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.

Trépo E, Pradat P, Potthoff A, Momozawa Y, Quertinmont E, Gustot T, Lemmers A, Berthillon P, Amininejad L, Chevallier M, Schlué J, Kreipe H, Devière J, Manns M, Trépo C, Sninsky J, Wedemeyer H, Franchimont D, Moreno C.

Hepatology. 2011 Jul;54(1):60-9. doi: 10.1002/hep.24350.

PMID:
21488075
19.

Impact of Il28b-related single nucleotide polymorphisms on liver transient elastography in chronic hepatitis C infection.

Ydreborg M, Westin J, Rembeck K, Lindh M, Norrgren H, Holmberg A, Wejstål R, Norkrans G, Cardell K, Weiland O, Lagging M.

PLoS One. 2013 Nov 14;8(11):e80172. doi: 10.1371/journal.pone.0080172. eCollection 2013.

20.

PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients.

Huang CF, Chen JJ, Yeh ML, Huang CI, Hsieh MY, Yang HL, Dai CY, Huang JF, Lin ZY, Chen SC, Chuang WL, Chen YL, Yu ML.

Sci Rep. 2015 Jul 3;5:11901. doi: 10.1038/srep11901.

Supplemental Content

Support Center